Actinium Pharmaceuticals CEO Sandesh Seth's 2021 pay jumps 27% to $2.3M

Actinium Pharmaceuticals reports 2021 executive compensation

By ExecPay News

Published: November 21, 2022

Actinium Pharmaceuticals reported fiscal year 2021 executive compensation information on November 21, 2022.
In 2021, four executives at Actinium Pharmaceuticals received on average a compensation package of $1M, a 5% decrease compared to previous year.
Average pay of disclosed executives at Actinium Pharmaceuticals
Sandesh Seth, Chief Executive Officer, received $2.3M in total, which increased by 27% compared to 2020. 55% of Seth's compensation, or $1.3M, was in option awards. Seth also received $430K in bonus and $615K in salary.
Steve O'Loughlin, Chief Financial Officer, received a compensation package of $967K, which increased by 18% compared to previous year. 46% of the compensation package, or $447K, was in option awards.
Mark Berger, Chief Medical Officer, earned $584K in 2021, a 30% decrease compared to previous year.
Dale Ludwig, Former Chief Scientific and Technology Officer, received $213K in 2021, which decreases by 74% compared to 2020.

Related executives

Sandesh Seth

Actinium Pharmaceuticals

Chief Executive Officer

Steve O'Loughlin

Actinium Pharmaceuticals

Chief Financial Officer

Mark Berger

Actinium Pharmaceuticals

Chief Medical Officer

Dale Ludwig

Actinium Pharmaceuticals

Former Chief Scientific and Technology Officer

You may also like

Source: SEC filing on November 21, 2022.